Apyx Medical (APYX) Depreciation & Amortization (CF) (2011 - 2026)
Apyx Medical's (APYX) quarterly Depreciation & Amortization (CF) came in at $196000.0 in Q2 2026, up 48.48% on a YoY basis from $132000.0 in Q2 2025, and down 2.97% quarter-over-quarter from $202000.0 in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $196000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Depreciation & Amortization (CF) rose 48.48% year-over-year to $196000.0; the trailing twelve-month figure through Jun 2026 stood at $783000.0 (up 40.83% YoY), and the FY2025 full-year result was $655000.0, up 9.35% from the prior year.
- Depreciation & Amortization (CF) eased to $196000.0 in Q2 2026 per APYX's latest filing, from $202000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $247000.0 in Q2 2022 and bottomed at $132000.0 in Q2 2025.
- Historically, Depreciation & Amortization (CF) has averaged $179666.7 across 5 years, with a median of $175000.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) plunged 38.87% in 2023, then soared 55.63% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $202000.0 in 2022, then retreated by 24.75% to $152000.0 in 2023, then dropped by 6.58% to $142000.0 in 2024, then jumped by 55.63% to $221000.0 in 2025, then dropped by 11.31% to $196000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $196000.0, $202000.0, and $221000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Apyx Medical | 130.67 Mn | 103.06 Mn | 8.87 Mn | 196,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 196,000.00 |
| Mar 31, 2026 | 202,000.00 |
| Dec 31, 2025 | 221,000.00 |
| Sep 30, 2025 | 164,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 142,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 157,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Sep 30, 2023 | 186,000.00 |
| Jun 30, 2023 | 151,000.00 |
| Mar 31, 2023 | 203,000.00 |
| Dec 31, 2022 | 202,000.00 |
| Sep 30, 2022 | 216,000.00 |
| Jun 30, 2022 | 247,000.00 |
| Mar 31, 2022 | 225,000.00 |
| Dec 31, 2021 | 229,000.00 |
| Sep 30, 2021 | 234,000.00 |